Primary and secondary immunodeficiency and other conditions requiring regular administration of octagam 5% or 10% ivig Clinical Trials

Delta Trials records 1 clinical trial for Primary and secondary immunodeficiency and other conditions requiring regular administration of octagam 5% or 10% ivig in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 29 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.